Ankylosing Spondylitis: focus on non-drug treatment
DOI:
https://doi.org/10.33448/rsd-v11i16.38202Keywords:
Ankylosing Spondylitis; Therapeutics; Physical Activity; Joints.Abstract
Introduction: Ankylosing Spondylitis (AS) is a type of chronic, autoimmune arthritis that primarily involves the spinal and sacroiliac joints. In more severe cases, this pathology can lead to a condition that results in loss of flexibility and fusion of the spine. Objective: To recognize viable and effective non-pharmacological treatment methods for the disease in question, given the great importance of the association with pharmacological treatment. Methodology: This is a descriptive research of the integrative literature review type, which sought to research the non-drug treatment of Spondylitis. The research was conducted through online access in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Google Scholar, Virtual Health Library (VHL) and EBSCO Information Services databases, in the months of September and October 2022. Results and discussion: Physical activities, whether aquatic or terrestrial, are of great value when related to non-drug treatment of diseases that course with bone and muscle pain, by delaying the progression of the pathology and improving the patient's quality of life. In addition, home exercises indicated by physical therapists can also help with the aforementioned benefits. Furthermore, it is important to associate this with drug or even surgical treatment, especially in cases that are already advanced. Conclusion: The least invasive forms of treatment for ankylosing spondylitis are those that refer to physical activity that, associated with early diagnosis and pharmacological treatment, contribute to therapeutic success, lower risk of sequelae and, therefore, to a better quality of life for the patient.
References
Bolonheis, V. P. (2022). Intervenções fisioterapêuticas para dor, rigidez matinal e capacidade funcional na espondilite anquilosante: uma revisão sistemática de ensaios controlados randomizados. 139 f., il. Tese (Doutorado em Ciências e Tecnologias em Saúde) — Universidade de Brasília.
Chen, Y et al. (2021). The efficacy and safety of Yijinjing exercise in the adjuvant treatment of ankylosing spondylitis: A protocol of randomized controlled trial. Medicine. 100(38), e27109.
Cunha, B. L. & Roveda, P. O. (2021). Tratamento fisioterapêutico de paciente com Espondilite Anquilosante: relato de experiência. Mostra de Extensão, Ciência e Tecnologia da Unisc. (2), 78.
Dantas, A. B. (2021). Eficácia e segurança do uso de imunobiológicos no tratamento de espondilite anquilosante e sua relação com a qualidade de vida dos pacientes acompanhados no Hospital Universitário Lauro Wanderley (HULW-UFPB). Universidade Federal da Paraíba, João Pessoa, PB.
Espahbodi, S. et al. (2016). Fatigue Is Associated with Work Productivity Impairment in Uk Patients with Axial Spondyloarthritis (AXSPA): A Cross-Sectional Observational Study: Annals of the Rheumatic Diseases, 75(2), 593.2-594.
Ferreira, M. I. da R. C. (2021). A Influência de um Programa de Exercícios em Meio Aquático, no Equilíbrio, em Doentes com Espondilite Anquilosante. Tese de Doutorado. Instituto Politecnico do Porto, Portugal.
Fraenkel, Liana et al. (2021). American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis & Rheumatology, 73(7), 1108-1123.
Gil, A. C. (2002). Como elaborar projetos de pesquisa, 4, 175. Atlas.
Guo., et al. (2022). Treatment of ankylosing spondylitis complicated with a thoracolumbar Andersson lesion by posterior closed osteotomy, debridement and fusion through the fracture line. BMC Musculoskelet Disord, v. 23, n. 1, p.815.
Gurpinar, B., Ilcin, N., Savci, S., & Akkoc, N. (2021). Do mobility exercises in different environments have different effects in ankylosing spondylitis?. Do mobility exercises in different environments have different effects in ankylosing spondylitis?. Acta reumatologica portuguesa, 46(4), 97–316.
Hwang, M. C. et al. (2021) “Ankylosing spondylitis risk factors: a systematic literature review.” Clinical rheumatology, 40(8), 3079-3093.
Lim, J. M., & Cho, O. H. (2021). Effects of Home-and-Workplace Combined Exercise for Patients with Ankylosing Spondylitis. Asian nursing research, 15(3), 181–188.
Molto, A. et al. (2016). Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort. Annals of the Rheumatic Diseases, 76(6), 1036–1041.
Nikiphorou, E. et al. (2022) “How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort”, Rheumatology, 61(5), 2034–2042.
Nolte, K., van Rensburg, D., & Fletcher, L. (2021). Effects of a 6-month exercise programme on disease activity, physical and functional parameters in patients with ankylosing spondylitis: Randomised controlled trial. The South African journal of physiotherapy, 77(1), 1546.
Regnaux, J. P et al. (2019). Exercise programmes for ankylosing spondylitis. The Cochrane database of systematic reviews, 10(10).
Rocha, D., & Deusdará, B. (2005). Análise de Conteúdo e Análise do Discurso: aproximações e afastamentos na (re) construção de uma trajetória. Alea: estudos neolatinos, (7), 305-322.
Sampaio, P. (2018). Efeitos da hidrocinesioterapia na Espondilite Anquilosante: um estudo de caso. Juazeiro do Norte, BA.
Shim, J. et al. Impact of biologic therapy on work in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis (BSRBR-AS) and meta-analysis. Rheumatology, 57(3).
Şilte Karamanlioğlu, D. et al. (2016). Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial. Rheumatology International, 36(5), 653–661.
Smolen, Josef S. et al. (2020). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases, 79(6), 685-699.
Vasconcelos, J. T. S. et al. (2020). Livro da Sociedade Brasileira de Reumatologia. (2a ed.) Manole. Cap. 24, p. 788.
Van der Heijde, D. et al. (2019). “Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis.” Rheumatology, Oxford, England, 58(3).
Xi, Y. et al. (2019) “Advances in nanomedicine for the treatment of ankylosing spondylitis.” International journal of nanomedicine, 14, 8521-8542.
Ytterberg, S. R. et al. (2022). Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. New England Journal of Medicine, 386(4), 316-326.
Zhu, Wei et al. (2019). “Ankylosing spondylitis: etiology, pathogenesis, and treatments.” Bone research, 7(22).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Leonardo Alvarenga Lucena; Luana Damaceno Miranda; Ruan Sousa Soares; Paula Andrade Amorim Rodrigues; Leandro Alves Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
